Medpark-Based XinCheng Medical Secures Hosting Rights for ISMCS 2026—First Time in China
magAssist
Developer of Extracorporeal Artificial Heart Devices
Recently,Medpark, Jiangsu Medical Device Technology Industrial ParkmagAssistParticipated in the bid for the "International Society for Mechanical Circulatory Support Annual Meeting (ISMCS 2026)", which was unanimously approved by the board of directors, securing the hosting rights for ISMCS 2026. This will be the first time in over 30 years since its establishment that the ISMCS annual meeting will be held in China.
International Society for Mechanical Circulatory Assistance(International Society for Mechanical Circulatory Support, ISMCS) is one of the most influential organizations in the global mechanical circulatory support field. The society’s members have either created, promoted, or improved nearly all existing, currently applied, or soon-to-be-released mechanical assist devices (VAD, Impella, ECMO). The conference was formerly known as the International Society for Rotary Blood Pumps (ISRBP) and was officially renamed the International Society for Mechanical Circulatory Support (ISMCS) in 2016. The annual meeting held each year attracts attention from peers worldwide.It has developed into the academic exchange platform for mechanical circulatory assistance with the largest disciplinary span and the most international influence.
It is reported that the venue for ISMCS 2026 has been set in Suzhou, with the tentative dates being October 22-24, 2026. The preparation work for ISMCS 2026 will be jointly advanced by a special committee consisting of the ISMCS Board, invited experts, and experts from the Chinese Mechanical Circulatory Support Society (CMCS), ensuring the smooth running of the conference and the presentation of high-quality academic content.
Not long ago, magAssist, a company within the Jiangsu Medical Device Technology Park Medpark, made a stunning appearance at the 50th European Society for Artificial Organs (ESAO) with its MoyoAssist® extracorporeal fully magnetically levitated artificial heart, receiving high praise from top experts in the international artificial organ field. At the recently concluded 30th Annual Meeting of the International Society for Mechanical Circulatory Support, magAssist presented the latest research achievements on multiple mechanical circulatory support technologies, including the MoyoAssist® extracorporeal fully magnetically levitated artificial heart and the NyokAssist® minimally invasive interventional artificial heart, showcasing Chinese wisdom and solutions to the world. With its innovative capabilities and strength, it has had a positive impact internationally and played a promoting role in the smooth progress of this application.
magAssist (Suzhou) Co., Ltd. is committed to building a new generation of extracorporeal life support platforms for critical care scenarios. Its main product lines include: minimally invasive interventional artificial heart, extracorporeal fully magnetically levitated artificial heart, warm blood organ transport platform, and a new generation of extracorporeal membrane oxygenation system (ECMO). The company aims to meet clinical needs across critical care extracorporeal life support scenarios by developing platforms tailored to different populations, varying support requirements, and diverse clinical settings.
Next, Medpark will continue to build"Technology-based Startups - High-tech Enterprises - Gazelle Enterprises - Unicorn Enterprises - Specialized and Innovative Enterprises - Listed Enterprises"Foster a梯队, create a forest of medical device sci-tech innovation enterprises, continuously optimize the selection, tracking service, and special assistance mechanisms for leading medical device companies, focus on cultivating a group of leading chain-owner enterprises with disruptive innovations, explosive growth, prominent competitive advantages, and high future output, and accelerate the industrialization and application of high-end medical devices.To achieve innovative medical devices that fill the gap in China.
Source: Jiaohuadian News
